Joint Formulary & PAD

Trospium chloride - Overactive bladder (adults)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Immediate release tablets
Associated Icons :
Restrictions / Comments :
Important
Alternative 1st line in patients where anticholinergic burden is a problem or on medicines that interact.
 

Status 2

Green (see narrative)
Formulations :
  • Modified release tablets
Associated Icons :
Restrictions / Comments :
Important
2nd line in patients where anticholinergic burden is a problem or on medicines that interact.

PAD Profile

ChemicalSubstance :
Trospium chloride
Indication :
Overactive bladder (adults)
Group Name :
Keywords :
antimuscarinics, OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, urinary urgency, anticholinergics
Brand Names Include :
Regurin, Regurin XL
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
6
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Trospium chloride is used to treat.

  • No records returned.

Committee Recommendations (2)

The APC supports patients in trialling a treatment break of their overactive bladder medicines.

A "Leaflet for trial of stopping anticholinergics" can be found in the documents section below.

Solifenacin is the 1st line treatment option.

Trospium immediate release or modified release are recommended as suitable treatment options where solifenacin is not suitable.

See Selection Tool for locally agreed OAB treatment options